All posts by sgriese

1st European Imprinting School 19.-21.05.2014

The European Imprinting Disorder School, first meeting.
19-21 May 2014
Mery-sur-Oise, close to Paris, France.

TOPIC Read more

ORGANIZING COMMITTEE Read more

SPEAKERS and CHAIRS Read more

VENUE, ACCOMMODATION and PROGRAMME Read more

REGISTRATION and GRANT Application Read more

Application Procedure for Short Term Scientific Missions

Short Term Scientific Missions (STSMs) is a COST instrument that aims at supporting young scientists in developing scientific collaborations and strengthening existing networks by granting stays in other COST countries to learn new techniques or to use methods for maximizing the exchange of experience among the participants as exchanging ideas and knowledge across borders. STSMs principally target young scientists. More information on the COST STSMs can be found here. We invite all members of this COST Action to apply for STSMs.

New EQA Scheme for Imprinting Disorders

The EU-funded COST network on Imprinting Disorders wishes to develop a new EMQN scheme for Beckwith-Wiedemann and Russel-Silver syndromes. To establish the status quo, the COST network would like to get a better unterstanding of what imprinting disorders labs are testing, and the methods used.

If you test for these disorders, please consider completing the short online survey which can be accessed using this link: http://www.surveymonkey.com/s/6YXDGDM

Alternatively, please contact Deborah Mackay (DJGM(at)soton.ac.uk) or Karen Gronskov (Karen.Groenskov(at)regionh.dk) on behalf of Prof. Thomas Eggermann, chair of the grant (teggermann(at)ukaachen.de).

EMQN Newletter October 2013 (pdf)

Spotlight on…

Cost Action representing European network for congenital Imprinting calls for partners to join them.

COST Action, BM1208, represents the recently established European network for congenital Imprinting disorders. This action currently includes more than 30 groups from 12 European countries (clinicians, geneticists, molecular biologists, patients organisations, SME), aiming on standardisation of treatment and diagnosis of Imprinting disorders (e.g. Prader-Willi, Angelman syndrome), on networking research and dissemination of findings. A specific website for the Network (http://www.imprinting-disorders.eu) is currently under construction. This is a growing network and is expecting more groups from 10 European countries (and non-European partners) to participate.
An interview with the Chair for a new COST Action, BM1208, Dr. Thomas Eggerman enlightens us with more information on the European network for Congenital Imprinting.

Read the entire interview here